Skip to content
Back to Guavy Wire
Stocks

Kennedy Faces Ethics Questions Over Gardasil Deal

Instruments
MRK
Share

Democratic lawmakers are criticizing Health and Human Services Secretary Robert F. Kennedy Jr. over alleged 'deviations' from his ethics agreement.

In a January 2025 ethics disclosure, Kennedy stated that he would earn a 10% contingency fee when referring cases to a law firm representing plaintiffs suing Merck over the HPV vaccine Gardasil.

Kennedy received over $850,000 through this deal in 2024, according to his ethics disclosure. However, he recently announced plans to divest his interest in prior litigation against Merck and have any proceeds from the lawsuit go to one of his sons instead.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc